Expression of bcl-2, bax and p53 protein in the basal cell carcinoma
Yan, L.; Chen, M.; Yu, G.
Hunan Yi Ke da Xue Xue Bao 24(2): 179-180
1999
ISSN/ISBN: 1000-5625 PMID: 11938785 Document Number: 509293
The expression of bcl-2, bax and p53 protein was studied in the basal cell carcinoma with 32 patients by immunohistochemical method. The results showed that bcl-2 protein was positive in 26 patients (81.2%), bax protein was positive in 9 patients(28.1%), and p53 protein was positive in 13 patients (40.6%); there is a negative correlation between the expression of bcl-2 and bax protein(P < 0.05). These findings suggest that apoptosis is suppressed which might cause the production of basal cell carcinoma.
Document emailed within 1 workday
Related Documents
Saitoh, M.; Yamada, T.; Shrestha, P.; Yamada, K.; Tsujimura, T.; Mori, M. 1996: Tenascin expression in adenoid basal cell carcinoma of the skin Anticancer Research 16(1): 129-134Habets, J.M.; Tank, B.; Vuzevski, V.D.; Brevé, J.; Stolz, E.; van Joost, T. 1988: Absence of cytokeratin 8 and inconsistent expression of cytokeratins 7 and 19 in human basal cell carcinoma Anticancer Research 8(4): 611-616
Kooy, A.J.; Tank, B.; de Jong, T.A.; Vuzevski, V.D.; Bosman, F.T.; van Joost, T. 1996: Expression of cytokeratin 8 in basal cell carcinoma: a comparative immunohistochemical and immunoelectron microscopy study Anticancer Research 16(1): 277-282
Requena, L.; Fariña, M.C.; Robledo, M.; Sangueza, O.P.; Sanchez, E.; Villanueva, A.; Marquina, A.; Tamarit, R. 1999: Multiple hereditary infundibulocystic basal cell carcinomas: a genodermatosis different from nevoid basal cell carcinoma syndrome Archives of Dermatology 135(10): 1227-1235
Stockfleth, E.; Ulrich, C.; Hauschild, A.; Lischner, S.; Meyer, T.; Christophers, E. 2002: Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod European Journal of Dermatology: Ejd 12(6): 569-572
Xue, L.-y.; Ren, L.-q.; Luo, W.; Guan, X.-j.; Zou, S.-m.; Zheng, S.; Bi, R.; Xie, Y.-q.; He, Z.-g.; Lü, N. 2007: Expression of Fas, Fas ligand, Fas-associated death domain protein, caspase 8 and mutant P53 protein in esophageal squamous cell carcinoma Zhonghua Yi Xue Za Zhi 87(3): 150-154
He, C.; Qin, C.; Xu, T.; Yuan, Y.; Liu, Z.; Sheng, Z.; Hu, F.; Dun, Y.; Wang, X. 2015: Expression of glycoprotein non-metastatic melanoma protein B in clear-cell renal cell carcinoma and clinical implication thereof Zhonghua Yi Xue Za Zhi 95(30): 2455-2458
Auepemkiate, S.; Boonyaphiphat, P.; Sriplung, H. 2000: P53 protein expression in cutaneous squamous cell carcinoma Journal of the Medical Association of Thailand 83(5): 543-548
Salem, S.A.; Gamal Aly, D.; Salah Youssef, N.; Moneim El-Shaer, M.A. 2015: Immunohistochemical assessment of endothelin-1 axis in psoriasis, basal cell carcinoma and squamous cell carcinoma Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 150(3): 283-291
Liao, Y-de.; Long, Q-hong.; Zhou, S.; Zhao, J-ping.; Huang, Q.; Fu, X-ning. 2005: Expression of PKB protein in human squamous-cell carcinoma and adenocarcinoma of lung Zhonghua Zhong Liu Za Zhi 27(3): 156-159
He, W.; Xiao, Y.; Chen, W.-m. 2015: Expression of Ki-67 and P53 protein in oral squamous cell carcinoma and its clinical significance Shanghai Kou Qiang Yi Xue 24(2): 228-231
Wollina, U.; Schönlebe, J.; Tchernev, G.; Chokoeva, A.A.; Lotti, T. 2015: Basal cell carcinoma or not Basal cell carcinoma? That is the question! Journal of Biological Regulators and Homeostatic Agents 29(1 Suppl): 81-86
Guan, W.; Yu, S.; Gao, Y. 2002: Expression of apoptosis-related protein in epithelial dysplasia and squamous cell carcinoma Zhonghua Kou Qiang Yi Xue Za Zhi 37(1): 65-68
Takenouchi, T. 2008: Diagnosis and treatment for squamous cell carcinoma and basal cell carcinoma of skin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(4): 591-595
Zhang, C.-Y.; Xiao, Z.-A.; Zeng, Y.-C.; Yang, X.-M.; Xie, D.-H.; Xia, K.; Liu, F.-Y.; Huang, B.-Y. 2008: Expression of stathmin mRNA and protein in laryngeal squamous cell carcinoma and its clinical implication Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 43(4): 291-295
Yamada, T.; Endo, R.; Tsukagoshi, K.; Fujita, S.; Honda, K.; Kinoshita, M.; Hasebe, T.; Hirohashi, S. 1996: Aberrant expression of a hemidesmosomal protein, bullous pemphigoid antigen 2, in human squamous cell carcinoma Laboratory Investigation; a Journal of Technical Methods and Pathology 75(4): 589-600
Li, S.-Y.; Yu, B.; An, P.; Liang, Z.-J.; Yuan, S.-J.; Cai, H.-Y. 2004: Effects of cell membrane phospholipid level and protein kinase C isoenzyme expression on hepatic metastasis of colorectal carcinoma Hepatobiliary and Pancreatic Diseases International: Hbpd Int 3(3): 411-416
Kazantseva, I.A.; Khlebnikova, A.N.; Babaev, V.R. 1994: Expression of various keratins in basal cell, metastatic, and squamous cell skin cancer Biulleten' Eksperimental'noi Biologii i Meditsiny 118(9): 300-303
Barr, R.J.; Graham, J.H. 1979: Granular cell basal cell carcinoma. a distinct histopathologic entity Archives of Dermatology 115(9): 1064-1067
Farhadi, M.; Kamrava, S.K.; Behzadi, A.H.; Rafiezadeh, P.; Asghari, A.; Rezvan, F.; Maleki, S. 2010: The efficacy of photodynamic therapy in treatment of recurrent squamous cell and basal cell carcinoma Journal of Drugs in Dermatology: Jdd 9(2): 122-126